CARDIAC PERFORMANCE IN END STAGE RENAL DISEASE DIABETIC PATIENTS WITH ARTERIOVENOUS FISTULA

被引:0
|
作者
Beigi, Ali-Akbar [1 ]
Khosravi, Alireza [2 ]
Sadeghi, Amir Mir-Mohammad [3 ]
Safaei, Mansour [4 ]
机构
[1] Isfahan Univ Med Sci, Chamran Hosp, Vasc Surg Dept, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Esfahan, Iran
[3] Kashan Univ Med Sci, Dept Gen Surg, Kashan, Iran
[4] Isfahan Univ Med Sci, Dept Surg, Esfahan, Iran
关键词
Fistulization; End Stage Renal Diseases; Cardiac Performance; Diabetes mellitus;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Access to vascular system needed for hemodialysis among patients in end stage renal disease (ESRD). Cardiac performance has been affected by chronic renal failure based on several known causes during diseases process. We have compared in this study some of cardiac performance indicators before and after fistulization in diabetic and non-diabetic ESRD patients. METHODS: Fifty ESRD patients were included in the study. Systolic pulmonary arterial pressure (PAP), cardiac output (CO) and ejection fraction (EF) were measured by echocardiography before fistulization and was repeated at least 8 months after fistulization. Data analyzed in diabetic and non-diabetic patients. RESULTS: Thirty four patients were included in analysis (28 men and 6 women). Mean time of follow up was 10.5 +/- 1.3 months. The mean of PAP before and after fistulization was 25.16 mmHg and 21.3 mmHg, respectively in all individuals (P > 0.05). The mean of cardiac output before and after making fistula was 5580 ml/min and 5680 ml/min, respectively (P < 0.05). Diabetic patients showed a significant reduction in their mean of cardiac ejection fraction before and after intervention (EF1 = 66.9%, EF2 = 51.4%) comparing with non-diabetic patients (EF1 = 58.5, EF2 = 57.5) (P < 0.05). PAP changes and CO changes had not any significant difference between diabetic and non-diabetic patients. DISCUSSION: Fistulization in ESRD patients can improve cardiac performance among these patients. This change may be differing among patients based on the cause of renal failure. Diabetes mellitus may be one of the parameters that can modulate this affect. This should be test in more detailed studies.
引用
收藏
页码:33 / 36
页数:4
相关论文
共 50 条
  • [31] Cardiac ischemia in the diabetic patient with end-stage renal disease
    Churchill, DN
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (04): : 305 - 308
  • [32] Increased Excess Pressure After Creation of an Arteriovenous Fistula in End-Stage Renal Disease
    Pare, Mathilde
    Goupil, Remi
    Fortier, Catherine
    Mac-Way, Fabrice
    Madore, Francois
    Hametner, Bernhard
    Wassertheurer, Siegfried
    Schultz, Martin G.
    Sharman, James E.
    Agharazii, Mohsen
    AMERICAN JOURNAL OF HYPERTENSION, 2022, 35 (02) : 149 - 155
  • [33] KIDNEY TRANSPLANTATION AMELORIATES CARDIAC FUNCTION IN DIABETIC PATIENTS WITH END-STAGE RENAL DISEASE
    Gurluler, Ercument
    Gures, Nazim
    Alim, Altan
    Gurkan, Alihan
    Cakir, Ulkem
    Berber, Ibrahim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 285 - 285
  • [34] Cardiac performance and morphology in end-stage renal disease
    Alpert, MA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 168 - 178
  • [35] Cardiac performance and morphology in end-stage renal disease
    Alpert, M
    ADVANCES IN HEART FAILURE, 2002, : 255 - 259
  • [36] HYPERMAGNESEMIA IN DIABETIC END STAGE RENAL DISEASE (ESRD) PATIENTS
    Shashidhar, K. N.
    Kunder, Mamatha
    Shenoy, K. Anitha
    Hemalatha, A.
    Kutty, A. V. M.
    Shetty, H. V.
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2007, 22 (02) : 164 - 164
  • [37] Effects of Arteriovenous Fistula on Blood Pressure in Patients With End-Stage Renal Disease: A Systematic Meta-Analysis
    Scholz, Sean S.
    Vukadinovic, Davor
    Lauder, Lucas
    Ewen, Sebastian
    Ukena, Christian
    Townsend, Raymond R.
    Wagenpfeil, Stefan
    Bohm, Michael
    Mahfoud, Felix
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (04):
  • [38] Hypermagnesemia in diabetic end stage renal disease (ESRD) patients
    K N Shashidhar
    Mamatha Kunder
    K Anitha Shenoy
    A Hemalatha
    AVM Kutty
    HV Shetty
    Indian Journal of Clinical Biochemistry, 2007, 22 (2) : 164 - 164
  • [39] The fate of end-stage renal disease patients after arteriovenous fistula creation in a northern Nigerian teaching hospital
    Edaigbini, Sunday
    Bosan, Istifanus
    Orogade, Adeola
    TROPICAL DOCTOR, 2016, 46 (03) : 135 - 137
  • [40] Predictive Factors for Unsuccessful Use of Arteriovenous Fistula in a Population of End-Stage Renal Disease Patients in Southeastern Mexico
    Martinez-Mier, Gustavo
    Camargo-Diaz, Cecilia
    Antonio Urbina-Velazquez, Marco
    Fabricio Avila-Pardo, Sandro
    ANNALS OF VASCULAR SURGERY, 2020, 62 : 304 - 309